TrialThe Journal of clinical endocrinology and metabolism2022

Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes.

Charlotte C van Ruiten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.